These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 190508)

  • 1. Differential distribution of opiate and neuroleptic receptors and dopamine-sensitive adenylate cyclase in rat brain.
    Leysen J; Laduron P
    Life Sci; 1977 Jan; 20(2):281-8. PubMed ID: 190508
    [No Abstract]   [Full Text] [Related]  

  • 2. The demonstration in vivo of specific binding sites for neuroleptic drugs in mouse brain.
    Höllt V; Czlonkowski A; Herz A
    Brain Res; 1977 Jul; 130(1):176-83. PubMed ID: 560239
    [No Abstract]   [Full Text] [Related]  

  • 3. Subcellular localization of dopamine-sensitive adenylate cyclase and dopamine receptor binding activities.
    Clement-Courmier Y; George R
    Life Sci; 1978 Aug; 23(6):539-43. PubMed ID: 692278
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of some derivatives of 2-aminotetralin on dopamine-sensitive adenylate cyclase and on the binding of (3H)haloperidol to neuroleptic receptors in the rat striatum.
    Cannon JG; Costall B; Laduron PM; Leysen JE; Naylor RJ
    Biochem Pharmacol; 1978 May; 27(10):1417-20. PubMed ID: 567987
    [No Abstract]   [Full Text] [Related]  

  • 5. Stereospecificity of interaction of neuroleptic drugs with neurotransmitters and correlation with clinical potency.
    Enna SJ; Bennett JP; Burt DR; Creese I; Snyder SH
    Nature; 1976 Sep; 263(5575):338-41. PubMed ID: 8733
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of butaclamol on dopamine-sensitive adenylate cyclase in the rat striatum.
    Miller RJ; Horn AS; Iversen LL
    J Pharm Pharmacol; 1975 Mar; 27(3):212-3. PubMed ID: 238011
    [No Abstract]   [Full Text] [Related]  

  • 7. Mu-, delta- and kappa-opioid receptor-mediated inhibition of neurotransmitter release and adenylate cyclase activity in rat brain slices: studies with fentanyl isothiocyanate.
    Schoffelmeer AN; Rice KC; Jacobson AE; Van Gelderen JG; Hogenboom F; Heijna MH; Mulder AH
    Eur J Pharmacol; 1988 Sep; 154(2):169-78. PubMed ID: 2906610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain receptors for antipsychotic drugs and dopamine: direct binding assays.
    Seeman P; Chau-Wong M; Tedesco J; Wong K
    Proc Natl Acad Sci U S A; 1975 Nov; 72(11):4376-80. PubMed ID: 1060115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of dopamine and beta-adrenergic sensitive adenylate cyclases in the frontal cerebral cortex of the rat. Comparative effects of neuroleptics on frontal cortex and striatal dopamine sensitive adenylate cyclases.
    Bockaert J; Tassin JP; Thierry AM; Glowinski J; Premont J
    Brain Res; 1977 Feb; 122(1):71-86. PubMed ID: 837225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipsychotic drug doses and neuroleptic/dopamine receptors.
    Seeman P; Lee T; Chau-Wong M; Wong K
    Nature; 1976 Jun; 261(5562):717-9. PubMed ID: 945467
    [No Abstract]   [Full Text] [Related]  

  • 11. Opioid receptors and inhibition of dopamine-sensitive adenylate cyclase in slices of rat brain regions receiving a dense dopaminergic input.
    Heijna MH; Bakker JM; Hogenboom F; Mulder AH; Schoffelmeer AN
    Eur J Pharmacol; 1992 Dec; 229(2-3):197-202. PubMed ID: 1337044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antipsychotic drugs and dopamine-stimulated adenylate cyclase prepared from corpus striatum of rat brain.
    Karobath M; Leitich H
    Proc Natl Acad Sci U S A; 1974 Jul; 71(7):2915-8. PubMed ID: 4527668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of brain receptor binding inhibition by endogenous macromolecular substances [proceedings].
    Van Gompel P; Leysen JE
    Arch Int Physiol Biochim; 1980 Feb; 88(1):B51-B53. PubMed ID: 6155859
    [No Abstract]   [Full Text] [Related]  

  • 14. Action of neuroleptic agents on histamine-sensitive adenylate cyclase in rabbit cerebral cortex.
    Spiker MD; Palmer GC; Manian AA
    Brain Res; 1976 Mar; 104(2):401-6. PubMed ID: 1260440
    [No Abstract]   [Full Text] [Related]  

  • 15. Interactions between opiate- and dopamine-induced effects on adenylate cyclase in rat striatum.
    O'Shaughnessy CT; Headley PM
    Eur J Pharmacol; 1986 Jun; 125(1):79-83. PubMed ID: 3015643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcellular localization of dopamine-sensitive adenylate cyclase in rat brain striatum.
    Laduron P; Verwimp M; Janssen PF; Leysen J
    Life Sci; 1976 Feb; 18(4):433-9. PubMed ID: 130527
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of dopamine-sensitive adenylate cyclase in rat basal ganglia and other hormone sensitive adenylate cyclase systems by neuroleptic drugs.
    Miller R
    Br J Pharmacol; 1975 Mar; 53(3):457P-458P. PubMed ID: 1137755
    [No Abstract]   [Full Text] [Related]  

  • 18. Subcellular distribution of dopamine-sensitive adenylate cyclase.
    Sieghart W; Leitich H; Karobath M
    Brain Res; 1976 Jun; 109(2):418-22. PubMed ID: 1276926
    [No Abstract]   [Full Text] [Related]  

  • 19. Differentiation of opiate and neuroleptic receptor binding in rat brain.
    Leysen J; Tollenaere JP; Koch MH; Laduron P
    Eur J Pharmacol; 1977 Jun; 43(3):253-67. PubMed ID: 194781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions between lysergic acid diethylamide and dopamine-sensitive adenylate cyclase systems in rat brain.
    Hungen KV; Roberts S; Hill DF
    Brain Res; 1975 Aug; 94(1):57-66. PubMed ID: 238721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.